Infinity Pharmaceuticals
Présence
Infinity Pharmaceuticals est une société cotée sous le symbole boursier INFI (US).
Acquisition, funding and merger involving Infinity Pharmaceuticals.
- Infinity Pharmaceuticals has filed for bankruptcy protection (publié le 2 octobre 2023).
- MEI Pharma has announced the acquisition of Infinity Pharmaceuticals (publié le 24 février 2023).
Dirigeants
Voir l'organigramme avec ses 10 principaux dirigeants
Biographies les plus recherchées chez Infinity Pharmaceuticals
Changements de dirigeants chez Infinity Pharmaceuticals
- Adelene Perkins, Chairman of the Board, President, Chief Executive Officer, a quitté l'entreprise (publié le 5 septembre 2023).
- Robert Ilaria, Chief Medical Officer, a quitté l'entreprise (publié le 5 septembre 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez Infinity Pharmaceuticals.
Biotechnologie
Infinity Pharmaceuticals a 2 276 concurrents dont Eurofins (Luxembourg), Lonza (Suisse) et Adaptive Phage Therapeutics (Etats—Unis).
Actualités en fusion/acquisition en Biotechnologie.
- Bruker has announced the acquisition of NanoString Technologies (publié le 18 avril 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (publié le 16 avril 2024).
- Nurix Therapeutics vient d'annoncer une levée de fonds de 175 millions de dollars. (publié le 13 avril 2024).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par Infinity Pharmaceuticals
- Press Releases | Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals Announces the Date of Its Second Quarter 2022 Financial Results Conference Call and Webcast | Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment Conference | Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results | Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals Announces the Date of Its First Quarter 2022 Financial Results Conference Call and Webcast | Infinity Pharmaceuticals, Inc.
- Press Releases | Infinity Pharmaceuticals, Inc.
- Infinity Receives Fast Track Designation for Eganelisib in Combination with a Checkpoint Inhibitor and Chemotherapy for First-Line Treatment of Advanced TNBC | Infinity Pharmaceuticals, Inc.
- Infinity to Present at Upcoming Investor Conferences in September | Infinity Pharmaceuticals, Inc.
- Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results | Infinity Pharmaceuticals, Inc.
- Infinity Announces the Date of Its Second Quarter Financial Results Conference Call and Webcast | Infinity Pharmaceuticals, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Infinity Pharmaceuticals
- Infinity Pharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- Infinity Pharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Seth Tasker 
Appelez Infinity Pharmaceuticals au +1 617...
